Home / Stocks / GLPL
Back to all stocks
BSE · GLPL

GOLDLINE PHARMACEUTICAL LIMITED (GLPL) Share Price

Sector: Healthcare · ISIN: INE1CLW01015

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,124
of 5,047 stocks
▼ 371W▼ 901M
Peak #3,962 · 21 Sep 2026

Operating in Healthcare, GOLDLINE PHARMACEUTICAL LIMITED trades at an undemanding earnings multiple, generates a high return on equity, and is growing revenue at a solid clip. Ownership as of May 2026.

Market Cap
20.42 Cr
P/E Ratio
4.96
P/B Ratio
1.43
ROE
28.89%
ROCE
39.98%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

Quarterly financials for this stock haven't been ingested yet — check back soon.

Shareholding pattern

Promoter
57.29%
Public
42.71%

PUBLIC BREAKDOWN

FII
5.16%
DII
7.81%
Individuals
25.14%

As of 17 May 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs